Read more
The right to Pharmaceutical Services (PS) in Brazil is part of the constitutional right to health. In order to ensure this right, the government must formulate and implement policies and actions that guarantee the population's access to essential medicines. This normative advance, by conferring on PS the status of a fundamental right, has given rise to recourse to judicial protection and has led to an increase in legal claims for the realisation of this right. This phenomenon is known as the judicialisation of PA. This work was developed and presented as a partial requirement for obtaining a master's degree in Biopharmaceutical Innovation from the Federal University of Minas Gerais. Under the guidance of Professor Dr Roberto Luiz Silva, from the Faculty of Law, and co-supervisor Dr Augusto Guerra, from the Faculty of Pharmacy, an analysis was carried out of the influence of the protection of intellectual property rights on the profile of medicines that are judicially demanded from the Minas Gerais State Health Department, on public spending and its interfaces with the rational use of medicines and the incorporation of new technologies into the Unified Health System (SUS).
About the author
Farmaceutka uköczy¿a Uniwersytet Federalny w Ouro Preto, specjalizuj¿c si¿ w zdrowiu publicznym i posiada tytu¿ magistra innowacji biofarmaceutycznych na Uniwersytecie Federalnym Minas Gerais (UFMG). Obecnie jest badaczk¿ i doktorantk¿ w dziedzinie leków i us¿ug farmaceutycznych na UFMG/Strathclyde University (Szkocja) oraz konsultantk¿ ad hoc w zakresie polityki zdrowia publicznego.
